腫瘍の dendritic 細胞における prosaposin の高糖化が免疫脱出を誘導する
Pankaj Sharma1, Xiaolong Zhang1, Kevin Ly1
1Program in Cellular and Molecular Medicine, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
Science (New York, N.Y.)
|January 11, 2024
まとめ
プロサポシン (pSAP) は,腫瘍に対するCD8T細胞の免疫を強化する. しかし, dendritic 細胞 (DCs) でのその高糖化が癌の免疫脱出を促進し,pSAP が免疫療法の治療標的であることを示唆しています.
科学分野:
- 免疫学
- 腫瘍学
- 細胞生物学
背景:
- 腫瘍は抗原を抑制することで 免疫検出を回避します
- プロサポシン (pSAP) は免疫反応に作用する.
研究 の 目的:
- CD8 T細胞媒介腫瘍免疫におけるプロサポシン (pSAP) の役割を調査する.
- dendritic 細胞 (DCs) のpSAP高糖化が癌の免疫脱出にどのように寄与するかを理解する.
主な方法:
- 抗原のプレゼンテーションにおけるリソソーマルpSAPおよびそのコネートの分析.
- 成長因子-β (TGF-β) がpSAPの糖化と分泌に及ぼす影響を調査する.
- メラノーマ患者の腫瘍関連DCにおけるpSAP発現の検査
- T細胞活性化に対するpSAP溶解の影響を評価する.
- 腫瘍モデルと免疫チェックポイント療法の治療の可能性を評価する.
主要な成果:
- リンソーム性pSAPは,アポプトティック腫瘍細胞からの抗原プレゼンテーションを促進し,T細胞の活性化を促進します.
- 変形成長因子β (TGF-β) は,pSAPの高糖化と分泌を誘導し,リソソームのソポシンを枯渇させる.
- メラノーマ患者の腫瘍関連DCではpSAP高糖化が観察されています.
- pSAPで復元すると,腫瘍に浸透するT細胞の活性化が回復する.
- リコンビナントのpSAPでDCをターゲットにすることで,腫瘍の保護と免疫チェックポイント療法の有効性を改善します.
結論:
- プロサポシン (pSAP) は,CD8T細胞媒介の抗腫瘍免疫に不可欠である.
- 腫瘍DCにおけるハイパーグリコシル化pSAPは,抗原プレゼンテーションを損なうことで,がんの免疫脱出を促進する.
- pSAPは,がんの免疫療法を強化するための潜在的な治療目標です.
関連する概念動画
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:24Oligosaccharide Assembly
2.9K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.9K